Diabetes Costs UK £14 Billion Annually
A recent study by the York Health Economics Consortium sheds light on the substantial economic toll of diabetes in the UK. In the fiscal year 2021/22, diabetes accounted for nearly £14 billion in costs, with over £10 billion directly affecting the NHS. This represents a significant 6% of the national health budget.
Breakdown of Costs: Direct vs. Indirect
The study examined costs associated with type 1 and type 2 diabetes, along with gestational diabetes. It revealed that more than 40% of expenses were diagnosis and treatment. Alarmingly, the remaining costs—exceeding £6 billion—stemmed from largely preventable complications.
Complications Remain a Primary Concern
Despite advancements in treatment and reduced costs related to complications compared to a decade ago, issues such as stroke, amputation, and angina still constitute the largest share of diabetes-related expenses. Indirect costs, including productivity loss due to work absence or mortality, amount to approximately £3.3 billion annually.
Call for Continued Investment and Prevention Strategies
Nick Hex, Associate Director at York Health Economics Consortium, emphasized the need for sustained investment in new technologies and prevention efforts. With a rise in type 2 diabetes among younger demographics, there is a pressing call to bolster strategies that mitigate future costs and health impacts.
Data Deficiencies and Care Improvements
The study underscored gaps in data collection, particularly concerning demographics like sex, ethnicity, and geographical location. Addressing these gaps is crucial for tailoring effective care and directing financial resources where they are most needed.
Advocacy for Early Intervention and Support
Diabetes UK, which supported the research, highlighted the opportunity to transform lives through early intervention and comprehensive support. They stressed the importance of shifting focus towards preventative care to alleviate the devastating toll of diabetes complications and reduce overall healthcare expenditures.
